PubRank

L Juillerat

Author PubWeight™ 9.02‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Interleukin-6 and tumor necrosis factor alpha levels after bisphosphonates treatment in vitro and in patients with malignancy. Bone 1996 1.14
2 Reactive hyperreninemia is a major determinant of plasma angiotensin II during ACE inhibition. J Cardiovasc Pharmacol 1990 0.85
3 Caffeine-induced diuresis and atrial natriuretic peptides. J Cardiovasc Pharmacol 1990 0.85
4 Angiotensin converting enzyme inhibition: discrepancy between antihypertensive effect and suppression of enzyme activity. J Cardiovasc Pharmacol 1989 0.83
5 Testing strategies for the safety of nanoparticles used in medical applications. Nanomedicine (Lond) 2009 0.83
6 Rapid measurement of total and active renin: plasma concentrations during acute and sustained converting enzyme inhibition with CGS 14824A. Clin Exp Hypertens A 1987 0.81
7 Need for plasma angiotensin measurements to investigate converting-enzyme inhibition in humans. Am Heart J 1989 0.80
8 Prevention of renal hypertension in the rat by neuropeptide Y. J Hypertens 1990 0.79
9 Effect of the renin response during renin inhibition: oral Ro 42-5892 in normal humans. J Cardiovasc Pharmacol 1991 0.78
10 Effects of smoking and physical exercise on platelet free cytosolic calcium in healthy normotensive volunteers. J Hypertens 1989 0.77
11 Astrocytes secrete a factor inducing the expression of HT7-protein and neurothelin in endothelial cells of chorioallantoic vessels. Adv Exp Med Biol 1993 0.75
12 [Hyperreactivity of the humeral artery to noradrenaline in essential hypertension patients]. Arch Mal Coeur Vaiss 1987 0.75
13 Increased response of brachial artery diameter to norepinephrine in hypertensive patients. Am J Physiol 1988 0.75